. Specifically, chemotactic factors and migration inhibition factors have been described which affect the motility of either polymorphonuclear leukocytes (PMN) or cells of the monocyte-macrophage system (4, 15, 16). Lymphokine-mediated activation of macrophages and monocytes, as measured by enhancement of their metabolic, phagocytic, and bacteriostatic capabilities, has also been reported (6, 7, 12, 17) .
Over the past 11 years, numerous biologically active substances, called lymphokines, have been demonstrated in the supernatants of in vitro cultures of antigen-or lectin-activated lymphocytes. These lymphokines have been considered in vitro correlates of cell-mediated immunity and are thought to play a role in host resistance to infectious microorganisms (4, 15) . Specifically, chemotactic factors and migration inhibition factors have been described which affect the motility of either polymorphonuclear leukocytes (PMN) or cells of the monocyte-macrophage system (4, 15, 16) . Lymphokine-mediated activation of macrophages and monocytes, as measured by enhancement of their metabolic, phagocytic, and bacteriostatic capabilities, has also been reported (6, 7, 12, 17) .
Recently, Lomnitzer et al. (10) reported that supernatants of phytohemagglutinin (PHA)-activated mononuclear cells can stimulate PMN metabolism and phagocytosis. Nevertheless, by using a standard assay, they could not detect correspondingly increased PMN bactericidal activity against Staphylococcus aureus. Since PMN bactericidal activity has been shown to be important to host immune defense against gramnegative bacteria (20) , we studied the ability of mononuclear cell supernatants to stimulate PMN killing of a gram-negative organism, Serratia marcescens. Our data indicate that supernatants oflectin-activated mononuclear cells can stimulate PMN bactericidal activity. Furthermore, the PMN stimulating factor (PSF) present in these supematants does not appear to have the functional characteristics of a serum opsonin.
MATERIALS AND METHODS Preparation of cells. Mononuclear cells, separated from normal human adult peripheral blood by dextran sedimentation followed by Ficoll-Hypaque density centrifugation (3), were washed three times with warm Ca2" and Mg2"-free Hanks balanced salt solution and then resuspended in RPMI 1640 containing 10% heat-inactivated and virus-screened fetal calf serum, 2% HEPES buffer (N-2-hydroxyethyl piperazine-N'-2-ethanesulfonic acid), and 1% glutamine. Similarly isolated PMN were cleared of erythrocytes by hypotonic saline lysis and then washed once with normal saline. These cells consisted of >98% viable PMN.
Production of a PSF. To produce a PSF, mononuclear cells were cultured at a concentration of 2 x 106 to 3 x 106 cells per ml in a fmal volume of 2 ml in loosely-capped plastic tubes (16 x 125 mm) lying nearly horizontal for 3 to 7 days at 37°C in 5% C02-humidified atmosphere. E-PHA, prepared according to the method of Weber et al. (19) (a gift of R. P. MacDermott), was added at concentrations ranging from 1 to 20 ,g/ml to experimental tubes at the start of the culture and to control supernatants after they had been separated from the cells. After mononuclear cell culture, all tubes were centrifuged at 250 x g for 15 min. The supernatants were decanted into vials and then either used directly or frozen at -20°C for subsequent use. Control cultures, run simultaneously, were identical to the experimental cultures with the 502 exception that they lacked PHA. After supernatant collection, however, PHA was added to control supernatants in amounts equivalent to those used to stimulate lymphokine production in the experimental tubes. This insured that any stimulated PMN bactericidal activity induced by experimental supernatants was not due to the direct effect of PHA on either PMN or bacteria.
Stimulation of PMN. After the final wash in normal saline, the isolated PMN were resuspended in supernatants from cultures of either PHA-activated or control mononuclear cells in volumes of 0.2 to 1.0 ml at a concentration of 20 x 106 per ml. The PMN were then preincubated for 3 h at 37°C in 5% C02-humidified atmosphere in 15-ml plastic conical centrifuge tubes lying nearly horizontal. PMN preincubated with supernatants of PHA-activated mononuclear cells are hereafter referred to as stimulated PMN, whereas PMN preincubated with control mononuclear cell supernatants are referred to as control PMN.
Bacteria. The bacteria used, S. marcescens, were of a strain isolated from a bacteremic patient and could be killed by PMN in cooperation with heatinactivated serum from normal adults. This PMN bactericidal activity did not require heat-labile components of complement. Also, the bacteria used were not killed by serum and complement in the absence of PMN.
PMN bactericidal assay. The bactericidal capability of PMN was tested in a modified form of the assay of Hirsch and Strauss (8) . Use of a microtiter plate in measuring PMN bactericidal activity was developed by J. C. Sadoff (personal communication, manuscript in preparation). We used a modification of this microtiter plate system which permitted bacterial dilution and dispersion in test tubes. The technique required a total volume of only 0.1 ml per well and allowed us to efficiently test numerous variables by using small amounts of sera, PMN, and supernatants. S. marcescens, taken during log-phase growth in Trypticase soy broth, were washed and appropriately diluted in Eagle medium. A 10-p1 amount (containing 1 x 106 bacteria) was then added to round-bottom microtiter wells containing 70 pl of a constant number (0.5 x 10' to 2 x 106) of a preincubated (stimulated or control) PMN. The remaining 20 1p in the reaction mixture consisted of various concentrations of heatinactivated normal human serum and/or complement and/or Eagle medium. Our source of complement was freshly frozen human agammaglobulinemic serum which was routinely tested for functionally active complement.
To determine PMN bactericidal activity, 10-,ul samples were taken from each well before and after 1 represents bacterial growth. Statistical analysis was performed by calculating the standard error of the bactericidal activity using propagation of error formulas based on a Poisson distribution of the bacterial counts (1) . P values were determined from the normal theory test of the difference in bactericidal activity of stimulated PMN as compared to that of control PMN assayed simultaneously.
RESULTS
The growth curves of representative experiments depicted in Fig. 1 supernatants, in the absence of PMN, were not directly bactericidal. Furthermore, PMN preincubated for 3 h with control mononuclear cell supernatants were able to kill bacteria in cooperation with serum opsonins as effectively as PMN that were not preincubated. This confirmed that the increased PMN bactericidal activity seen in our system was indeed owing to increased activity of stimulated PMN and not decreased activity of control PMN.
As shown in Table 1 (experiments 1 through 4) and in the representative experiment graphed in Fig. 1A , in the absence of serum antibody and complement, control PMN were unable to impede bacterial growth during the 2-h bactericidal assay. Under these same conditions, stimulated PMN, tested simultaneously, killed a mean of 0.61 log (73%) and 0.68 log (76%) of the initial inoculum at 1 and 2 h, respectively. In experiments performed early in our investigations, activated mononuclear cell supernatants could not induce (or increase) PMN bactericidal activity when preincubated with PMN for only 1 h; the supernatants were also not effective when merely added to PMN in the bactericidal assay (i.e., without preincubation). The mechanism of action of PSF, therefore, is decidedly different from that of serum opsonins which effectively promote PMN bactericidal activity without preincubation with PMN (e.g., Table 1 and Fig. 2A ) or varying degrees of bactericidal activity depending on the amount of serum antibody added (Table 1 , experiments 11 through 17 and Fig. 2B and 3A) . Under each of these experimental conditions, stimulated PMN exhibited significantly increased bactericidal activity compared with that of control PMN tested simultaneously (see P values, Table 1 ). Even in the presence of both complement and 10% serum, after 60 min of test incubation, stimulated PMN killed an average of 0.60 log more of bacteria than simultaneously tested control PMN; after 120 min, an average 0.65 log more of bacteria were killed by stimulated PMN. Experiments performed in the presence of 10% serum but in the absence of complement also demonstrated significant PSF activity (Table 1 , experiments 18 through 20 and Figure 3B ). Considering all of the above data, the effect of activated mononuclear cell supernatants appears to be independent of the effects of antibody and complement.
DISCUSSION
The precise nature of the PSF we have described is presently unknown. Since stimulating activity could not be demonstrated when PMN were incubated with activated mononuclear cell supernatants for 1 h or less, PSF does not appear to have the functional characteristics of a serum opsonin. Furthermore, PHA has been shown to inhibit antibody production in vitro (18) . It is therefore highly unlikely that the biologically active factor in our PHA-stimulated supernatants is specific opsonic antibody. Stimulated mononuclear cells have been shown to secrete complement components (9) . Unlike PSF, however, when serum complement (known to be physiologically active) was preincubated with PMN for 3 h, it could not stimulate bactericidal activity in our system (data not shown). This suggests that PSF is not identical to serum complement.
The lack of increased PMN bactericidal activ- (2) .
We speculate that such activatable enzymes may be important to the preincubation that is necessary for PSF activity. Biochemical and physical characteristics of PSF need to be performed to distinguish it from other lymphokines which may affect PMN such as chemotactic factor and leukocyte inhibition factor. Alternatively, stimulation of PMN bactericidal activity may be an additional function of these previously described lymphokines. It would not be unusual for one factor to have more than one biological function. Nathan et al. (13) clearly demonstrated that the lymphokine in stimulated lymphocyte supernatants responsible for macrophage activation (as measured by adherence, phagocytosis, and glucose oxidation) could not be distinguished physiochemically from the migration inhibitory factor. It is also possible that the active moiety in our stimulated mononuclear supernatants is tuftsin, the phagocytosis-stimulating tetrapeptide isolated from normal sera (5) . Although to our knowledge, in vitro lymphocyte production of tuftsin has not been described previously, it is likely that tuftsin is a mononuclear cell product since it is deficient in the sera of splenectomized patients (5) .
Since both lymphocytes and monocytes are present in our mononuclear cell cultures, and since both cell types are capable of producing a variety of biologically active substances (17) , it would be premature at present to assume that the PSF described in this paper is lymphocyte derived. Preliminary results from our laboratories, however, indicate that PSF activity is present in supernatants of a nonphagocytic longterm cultured lymphoid cell line (G. H. Lowell and A. S. Cross, Fed. Proc. 37: 6, 1978) .
Whatever the nature and source of the factor, it would be interesting to determine whether purified bacterial antigens could also cause lymphocytes to secrete a PSF. If this were to occur in vitro (e.g., after infection or immunization), lymphokine-mediated stimulation of PMN bactericidal activity might then be considered an additional immune defense mechanism whereby hosts clear invading microorganisms.
